Retraction: Human Epididymis Protein-4 (HE-4): A Novel Cross-Class Protease Inhibitor(PLoS ONE (2012) 7:11 (e47672) DOI: 10.1371/journal.pone.0047672);Human Epididymis Protein-4 (HE-4): A Novel Cross-Class Protease Inhibitor

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Chhikara, Nirmal ^a   Saraswat, Mayank ^a,b   Tomar, Anil Kumar ^a   Dey, Sharmistha ^a   Singh, Sarman ^a   Yadav, Savita ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868347615     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0305589     Document Type: Erratum

References (58)

1. Chimpanzee Sequencing and Analysis Consortium (2005) Initial sequence of the chimpanzee genome and comparison wth the human genome. Nature 437: 69-87.
2. Hurle B, Swanson W, (2007) NISC Comparative Sequencing Program (2007) Green ED, (2007) Green Comparative sequence analyses reveal rapid and divergent evolutionary changes of the WFDC locus in the primate lineage. Genome Res 17: 276-286.
3. Larsen M, Ressler SJ, Gerdes MJ, Lu B, Byron M, et al. (2000) The WFDC1 gene encoding ps20 localizes to 16q24, a region of LOHin multiple cancers. Mamm Genome 11: 767-773.
4. Trexler M, Bányai L, Patthy L, (2001) A human protein containing multiple types of protease-inhibitory modules. Proc Natl Acad Sci U S A 98: 3705-3709.
5. Trexler M, Bányai L, Patthy L, (2002) Distinct expression pattern of two related human proteins containing multiple types of protease-inhibitory modules. Biol Chem 383: 223-228.
6. del Castillo I, Cohen-Salmon M, Blanchard S, Lutfalla G, Petit C, (1992) Structure of the X-linked Kallmann 452 syndrome gene and its homologous pseudogene on the Y chromosome. Nat Genet 2: 305-310.
7. Tanner MM, Grenman S, Koul A, Johannsson O, Meltzer P, et al. (2000) Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 6: 1833-1839.
8. Larramendy ML, Lushnikova T, Björkqvist AM, Wistuba II, Virmani AK, et al. (2000) Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines. Cancer Genet Cytogenet 119: 132-138.
9. Devoogdt N, Hassanzadeh Ghassabeh G, Zhang J, Brys L, De Baetselier P, et al. (2003) Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells. Proc Natl Acad Sci USA 100: 5778-5782.
10. Devoogdt N, Revets H, Ghassabeh GH, De Baetselier P, (2004) Secretory leukocyte protease inhibitor in cancer development. Ann NY Acad Sci 1028: 380-389.
11. Tian X, Shigemasa K, Hirata E, Gu L, Uebaba Y, et al. (2004) Expression of human kallikrein 7 (hK7/SCCE) and its inhibitor antileukoprotease (ALP/SLPI) in uterine endocervical glands and in cervical adenocarcinomas. Oncol Rep 12: 1001-1006.
12. Robinson PA, Markham AF, Schalkwijk J, High AS, (1996) Increased elafin expression in cystic, dysplastic and neoplastic oral tissues. J Oral Pathol Med 25: 135-139.
13. Zhang M, Zou Z, Maass N, Sager R, (1995) Differential expression of elafin in human normal mammary epithelial cells and carcinomas is regulated at the transcriptional level. Cancer Res 55: 2537-2541.
14. Schalkwijk J, Wiedow O, Hirose S, (1999) The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core. Biochem J 340: 569-577.
15. Sallenave JM, Shulmann J, Crossley J, Jordana M, Gauldie J, (1994) Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol 11: 733-741.
16. Bingle L, Cross SS, High AS, Wallace WA, Rassl D, et al. (2006) WFDC-2 (HE-4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Respir Res 7: 61.
17. Williams SE, Brown TI, Roghanian A, Sallenave JM, (2006) SLPI and elafin: one glove, many fingers. Clin Sci (Lond.) 110: 21-35.
18. Moreau T, Baranger K, Dadé S, Dallet-Choisy S, Guyot N, et al. (2008) Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family. Biochimie 90: 284-295.
19. Bingle CD, Vyakarnam A, (2008) Novel innate immune functions of the whey acidic protein family. Trends Immunol 29: 444-453.
20. Israeli O, Goldring-Aviram A, Rienstein S, Ben-Baruch G, Korach J, et al. (2005) In silico chromosomal clustering of genes displaying altered expression patterns in ovarian cancer. Cancer Genet Cytogenet 160: 35-42.
21. Kirchhoff C, Habben I, Ivell R, Krull N, (1991) A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. Biol Reprod 45: 350-357.
22. Galgano MT, Hampton GM, Frierson HF Jr, (2006) Comprehensive analysis of HE-4 expression in normal and malignant human tissues. Mod Pathol 19: 847-53.
23. Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, et al. (2003) Gene expression patterns in ovarian carcinomas. Mol Biol Cell 14: 4376-4386.
24. Hellstrom I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, et al. (2003) The HE-4 (WFDC-2) protein is a biomarker for ovarian carcinoma. Cancer Res 63: 3695-3700.
25. Drapkin R, von Horsten HH, Lin Y, Mok SC, Crum CP, et al. (2005) Human epididymis protein 4 (HE-4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res 65: 2162-2169.
26. Ramachandran P, Boontheung P, Xie Y, Sondej M, Wong DT, et al. (2006) Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry. J Proteome Res 5: 1493-1503.
27. Jin L, Wu WH, Li QY, Zhao YF, Li YM, (2011) Copper inducing Aβ42 rather than Aβ40 nanoscale oligomer formation is the key process for Aβ neurotoxicity. Nanoscale 3: 4746-4751.
28. Lee TM, Lin YH, (1995) Trypsin inhibitor and trypsin-like protease activity in air- or submergence-grown rice (Oryza sativa L.) coleoptiles. Plant Science 106: 43-54.
29. Chou CL, Sadegh-Nasseri S, (2000) HLA-DM Recognizes the Flexible Conformation of Major Histocompatibility Complex Class II. J Exp Med 192: 1697-1706.
30. Korsten H, Ziel-van der Made A, Ma X, van der Kwast T, Trapman J, et al. (2009) Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model. PLoS One 4: e5662.
31. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, et al. (2005) A human protein-protein interaction network: a resource for annotating the proteome. Cell 122: 957-968.
32. Ace CI, Okulicz WC, (2004) Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase. Reprod Biol Endocrinol 2: 54.
33. Perez-Vilar J, Hill RL, (1997) Norrie disease protein (norrin) forms disulfide-linked oligomers associated with the extracellular matrix. J Biol Chem 272: 33410-33415.
34. Li PP, Nakanishi A, Clark SW, Kasamatsu H, (2002) Formation of transitory intrachain and interchain disulfide bonds accompanies the folding and oligomerization of simian virus 40 Vp1 in the cytoplasm. Proc Natl Acad Sci U S A 99: 1353-1358.
35. De Lamirande E, (2007) Semenogelin, the main protein of the human semen coagulum, regulates sperm function. Semin Thromb Hemost 33: 60-68.
36. Bingle L, Singleton V, Bingle CD, (2002) The putative ovarian tumour marker gene HE-4 (WFDC-2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms. Oncogene 21: 2768-27673.
37. Hu Y, González-Martínez D, Kim SH, Bouloux PM, (2004) Cross-talk of anosmin-1, the protein implicated in X-linked Kallmann's syndrome, with heparan sulphate and urokinase-type plasminogen activator. Biochem J 384: 495-505.
38. Tokuishi K, Yamashita S, Ohbo K, Kawahara K, (2012) Splice variant HE-4-V3 expression is associated with favorable prognosis in pulmonary adenocarcinoma. Tumour Biol 33: 103-109.
39. Ardelt W, Laskowski M Jr, (1985) Turkey ovomucoid third domain inhibits eight different serine proteinases of varied specificity on the same Leu18-Glu19 reactive site. Biochemistry 24: 5313-5320.
40. Eggers CT, Wang SX, Fletterick RJ, Craik CS, (2001) The role of ecotin dimerization in protease inhibition. J Mol Biol 308: 975-991.
41. Eisenberg SP, Hale KK, Heimdal P, Thompson RC, (1990) Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. J Biol Chem 265: 7976-7981.
42. Schill WB, (1976) Quantitative determination of high molecular weight serum proteinase inhibitors in human semen. Andrologia 8: 359-364.
43. Birkenmeier G, Usbeck E, Schäfer A, Otto A, Glander HJ, (1998) Prostate-specific antigen triggers transformation of seminal alpha2-macroglobulin (alpha2-M) and its binding to alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein (alpha2-M-R/LRP) on human spermatozoa. Prostate 36: 219-225.
44. Ahlgren G, Rannevik G, Lilja H, (1995) Impaired secretory function of the prostate in men with oligo-asthenozoospermia. J Androl 16: 491-498.
45. Siezen RJ, de Vos WM, Leunissen JA, Dijkstra BW, (1991) Homology modelling and protein engineering strategy of subtilases, the family of subtilisin-like serine proteinases. Protein Eng Oct 4: 719-737.
46. Huang X, Zhao N, Zhang K, (2004) Extracellular enzymes serving as virulence factors in nematophagous fungi involved in infection of the host. Res Microbiol 155: 811-816.
47. St Leger RJ, (1995) The role of cuticle-degrading proteases in fungal pathogenesis of insects. Can J Bot 73: 1119-1125.
48. Sreedhar L, Kobayashi DY, Bunting TE, Hillman BI, Belanger FC, (1999) Fungal proteinase expression in the interaction of the plant pathogen Magnaporthe poae with its host. Gene 235: 121-129.
49. Bryant MK, Schardl CL, Hesse U, Scott B, (2009) Evolution of a subtilisin-like protease gene family in the grass endophytic fungus Epichloë festucae. BMC Evol Biol 9: 168.
50. Dickinson DP, (2002) Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit Rev Oral Biol Med 13: 238-275.
51. Lecaille F, Kaleta J, Brömme D, (2002) Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. Chem Rev 102: 4459-4488.
52. Sajid M, Robertson SA, Brinen LS, McKerrow JH, (2011) Cruzain: the path from target validation to the clinic. Adv Exp Med Biol 712: 100-115.
53. Tang J, James MN, Hsu IN, Jenkins JA, Blundell TL, (1978) Structural evidence for gene duplication in the evolution of the acid proteases. Nature 271: 618-621.
54. Blundell TL, Srinivasan N, (1996) Symmetry, stability, and dynamics of multidomain and multicomponent protein systems. Proc Natl Acad Sci USA 93: 14243-14248.
55. Laemmli UK, Mölbert E, Showe M, Kellenberger E, (1970) Form-determining function of genes required for the assembly of the head of bacteriophage T4. J Mol Biol 49: 99-113.
56. Hassan MI, Kumar V, Kashav T, Alam N, Singh TP, et al. (2007) Proteomic approach for purification of seminal plasma proteins involved in tumor proliferation. J Sep Sci 30: 1979-1988.
57. Pandhare J, Deshpnde V, (2004) Both chaperone and isomerase functions of protein disulfide isomerase are essential for acceleration of the oxidative refolding and reactivation of dimeric alkaline protease inhibitor. Protein Sci 13: 2493-501.
58. Schägger H, Cramer WA, von Jagow G, (1994) Analysis of molecular masses and oligomeric states of protein complexes by bluenative electrophoresis and isolation of membrane protein complexes by two-dimensional native electrophoresis. Anal Biochem 217: 220-30.